JPRN-jRCT2080221337终止1 期
A Phase I/II Study of WT4869 in Patients with Myelodysplastic Syndromes (MDS)
适应症
试验速览
- 阶段
- 1 期
- 状态
- 终止
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Phase I: histologically and/or cytologically confirmed WHO-defined MDS
- •- Phase II: histologically and/or cytologically confirmed MDS (WHO-defined) or refractory anemia with excess blasts in transformation (RAEB-t, FAB-defined)
- •- 18 years or older
- •- Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
- •- HLA-A*2402
排除标准
- •- Patients with concomitant infectious disease that requiring systemic antibiotics, systemic antiviral drugs or other treatment
- •- Pregnant or lactating females
- •- Anti-HIV antibody, HBs antigen or anti-HCV antibody positivity in the last 3 months prior to enrollment
研究者
相似试验
进行中（未招募）
1 期
A Study of LY2784544 in patients with blood cancerEUCTR2011-001012-56-DEEli Lilly and Company121
进行中（未招募）
1 期
A Study of LY2784544 in patients with blood cancerEUCTR2011-001012-56-ATEli Lilly and Company188
进行中（未招募）
不适用
A Study of LY2784544 in patients with blood cancerEUCTR2011-001012-56-SEEli Lilly and Company121
进行中（未招募）
不适用
A Study of LY2784544 in Patients with blood cancerMyeloproliferative neoplasms (MPNs), myelofibrosis, essentialthrombocythemia, and polycythemia veraMedDRA version: 15.0Level: LLTClassification code 10036061Term: Polycythemia veraSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 15.0Level: PTClassification code 10028537Term: MyelofibrosisSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 15.0Level: PTClassification code 10015493Term: Essential thrombocythaemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-001012-56-ITELI LILLY AND COMPANY188
进行中（未招募）
不适用
Study with Myeloproliferative NeoplasmsMyeloproliferative NeoplasmsMedDRA version: 14.1Level: HLTClassification code 10028578Term: Myeloproliferative disorders (excl leukaemias)System Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2011-001012-56-ESilly S.A150